Record #1 of 2
@article{Tort22,
author = {Tort, Sera, and Fong, Kwun M},
title = {What are the benefits and harms of non‐checkpoint‐based immunotherapy in people with stage I to III non‐small cell lung cancer (NSCLC) treated with surgery or chemoradiotherapy with curative intent?},
journal = {Cochrane Clinical Answers},
year = {2022},
DOI = {10.1002/cca.3934},
URL = {http://dx.doi.org/10.1002/cca.3934}
}


Record #2 of 2
@article{Mocellin21,
author = {Mocellin, Simone},
title = {How do immune checkpoint inhibitors (ICIs) compare with platinum‐based chemotherapy for people with advanced non‐small cell lung cancer (NSCLC)?},
journal = {Cochrane Clinical Answers},
year = {2021},
DOI = {10.1002/cca.3535},
URL = {http://dx.doi.org/10.1002/cca.3535}
}


